The YouGov survey, commissioned by NU, found 57 per cent of 3,944 people surveyed support the decision to allow patients to pay for private drugs while still receiving NHS treatment. A further 65 per cent felt the original ban on privately funded treatments was “unfair”, and 70 per cent welcome the introduction of top-ups for cancer drugs.
However, 57 per cent have expressed concerns over whether lifting the ban will create an unfair health system.
NU head of clinical governance Dr Doug Wright says: “This survey makes abundantly clear the strong level of support for top-ups, particularly for
cancer drugs. But while many are opposed to the ban on top-ups, a question remains around fairness and how to fund top-ups. There are no easy answers here, and the Government’s consultation will be important in clarifying the detail of the scheme, as well as roles and responsibilities.”
Wright says healthcare insurers now need to understand its role around providing cover for consumers, and establish a way to work alongside the NHS to deliver in the best interests of all patients.